Sort   by:  
 Page size 
UnknownPrediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score.
Not available
S-EPMC10111134 | biostudies-literature
UnknownPrevalence of Use and Cost of Biological and Non-Biological Targeted Therapies for Cancer Treatment: A 5-Year Picture from Southern Italy.
Not available
S-EPMC5834595 | biostudies-literature
UnknownAuthor Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy.
Not available
S-EPMC5834583 | biostudies-literature
UnknownTreating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials.
Not available
S-EPMC10242061 | biostudies-literature
UnknownImpact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair.
Not available
S-EPMC12202617 | biostudies-literature
UnknownAdjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study.
Not available
S-EPMC11325348 | biostudies-literature
UnknownIdentification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.
Not available
S-EPMC5355306 | biostudies-literature
UnknownFrequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype.
Not available
S-EPMC11839797 | biostudies-literature
UnknownNegative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy.
Not available
S-EPMC6864846 | biostudies-literature
UnknownIndependent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy.
Not available
S-EPMC8172481 | biostudies-literature
Sort   by:  
 Page size